OGHVD

Clinical trials for OGHVD explained in plain language.

Never miss a new study

Get alerted when new OGHVD trials appear

Sign up with your email to follow new studies for OGHVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New eye drop trial offers hope for painful dry eye condition

Disease control Recruiting now

This study is testing whether a new eye drop called d-MAPPS™ can safely reduce the severe dry eye symptoms caused by chronic ocular graft-versus-host disease (oGVHD). Adult patients with this condition will use the eye drops or a placebo for about 90 days to see if their eye disc…

Matched conditions: OGHVD

Phase: PHASE1, PHASE2 • Sponsor: Regenerative Ocular Immunobiologics LLC • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

OGHVD

Get alerted when new OGHVD trials appear

New eye drop trial offers hope for painful dry eye condition